Tag Archives: ONDCP

With Cannabis, Science Trumps Culture, Says GW Pharma CEO

Already approved in 22 countries, GW Pharma’s Sativex product, if approved by FDA, would become the first prescription drug derived from raw cannabis to enter the US market. In the last several years, the US – a place where marijuana still has a decidedly bad reputation, and a prosecutorial history tinged with socioeconomic bias, if […]
Posted in Europe, FDA, Global, Legal, People, R&D, Regulatory, Strategy, Technology | Also tagged , , , , , , , | 2 Comments
  • Categories

  • Meta